Cargando…
Investigation of the Suitability of a Commercial Radiation Sensor for Pretherapy Dosimetry of Radioiodine Treatment Patients
Radioiodine (I-131) therapy is routinely used to treat conditions of the thyroid. Dosimetry planning in advance of I-131 therapy has been shown to improve patient treatment outcomes. However, this pretherapy dosimetry step requires multiple outpatient appointments and is not feasible for patients li...
Autores principales: | O’Callaghan, Janet, Cody, Dervil, Cooke, Jennie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739645/ https://www.ncbi.nlm.nih.gov/pubmed/36502094 http://dx.doi.org/10.3390/s22239392 |
Ejemplares similares
-
The Role of Pretherapy Quantitative Imaging and Dosimetry in Radioiodine Therapy for Advanced Thyroid Cancer
por: Taprogge, Jan, et al.
Publicado: (2023) -
Retrospective Biological Dosimetry at Low and High Doses of Radiation and Radioiodine Impact on Individual Susceptibility to Ionizing Radiation
por: Cebulska-Wasilewska, Antonina, et al.
Publicado: (2017) -
Uncertainty quantification of bioassay functions for the internal dosimetry of radioiodine
por: Kwon, Tae-Eun, et al.
Publicado: (2020) -
Use of Pretherapy Core Biopsy in the Diagnosis of Pediatric Renal Tumors
por: Kurian, Jujju Jacob, et al.
Publicado: (2018) -
Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer
por: Pacilio, Massimiliano, et al.
Publicado: (2022)